Antibody-Based Therapeutics for Cancer

Organizer(s): Louis M. Weiner and Paul Carter

Sponsored by Genentech, Inc. and The Director's Fund

For important information on the coronavirus, please click here

Summary of Meeting:

Monoclonal antibodies have emerged as increasingly important therapeutic vehicles for the treatment of cancer and other human diseases. Selected un-conjugated antibodies can exert clinically meaningful anti-tumor effects in important cancers such as breast cancer and lymphoma. The mechanisms underlying these exciting results remain to be elucidated, but most likely include the induction of host immune responses and the perturbation of signaling through growth factor receptors. Antibody conjugates have been used to deliver toxic principles such as radioactive particles, chemotherapy agents and catalytic toxins with increasing success in defined clinical settings. Advances in antibody engineering have permitted the systematic evaluation of structural manipulation on targeting and efficacy. Antibodies with novel specificities can be isolated with increasing ease from naive and immunized phage display libraries. Major challenges in this rapidly evolving field include the development of improved means for identifying new functional targets for antibody perturbation.

Discounted Abstract Deadline: October 18 2004

Discounted Registration Deadline: December 17 2004

We gratefully acknowledge additional support for this conference from:

Bayer USA Foundation

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Genentech, Inc.

Seattle Genetics, Inc.

Xencor, Inc.

We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13-CA112789-01

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations